全文获取类型
收费全文 | 550篇 |
免费 | 25篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 8篇 |
妇产科学 | 9篇 |
基础医学 | 90篇 |
口腔科学 | 4篇 |
临床医学 | 58篇 |
内科学 | 77篇 |
皮肤病学 | 13篇 |
神经病学 | 59篇 |
特种医学 | 15篇 |
外科学 | 42篇 |
综合类 | 9篇 |
预防医学 | 35篇 |
眼科学 | 1篇 |
药学 | 93篇 |
肿瘤学 | 57篇 |
出版年
2023年 | 2篇 |
2022年 | 4篇 |
2021年 | 6篇 |
2020年 | 2篇 |
2019年 | 6篇 |
2018年 | 13篇 |
2017年 | 3篇 |
2016年 | 5篇 |
2015年 | 16篇 |
2014年 | 9篇 |
2013年 | 15篇 |
2012年 | 15篇 |
2011年 | 27篇 |
2010年 | 12篇 |
2009年 | 9篇 |
2008年 | 26篇 |
2007年 | 31篇 |
2006年 | 32篇 |
2005年 | 20篇 |
2004年 | 25篇 |
2003年 | 37篇 |
2002年 | 20篇 |
2001年 | 31篇 |
2000年 | 30篇 |
1999年 | 19篇 |
1998年 | 6篇 |
1997年 | 13篇 |
1996年 | 9篇 |
1995年 | 3篇 |
1994年 | 2篇 |
1993年 | 6篇 |
1992年 | 10篇 |
1991年 | 13篇 |
1990年 | 13篇 |
1989年 | 7篇 |
1988年 | 13篇 |
1987年 | 8篇 |
1986年 | 18篇 |
1985年 | 11篇 |
1984年 | 6篇 |
1983年 | 7篇 |
1982年 | 4篇 |
1980年 | 2篇 |
1978年 | 2篇 |
1976年 | 1篇 |
1975年 | 2篇 |
1974年 | 2篇 |
1971年 | 2篇 |
1967年 | 1篇 |
1966年 | 2篇 |
排序方式: 共有578条查询结果,搜索用时 0 毫秒
1.
2.
Kathleen M. Giacomini 《Journal of pharmacokinetics and pharmacodynamics》1997,25(6):731-741
Many clinically used drugs and their metabolites as well as a variety of environmental toxins are organic cations at physiologic pH. Secretion in the renal proximal tubule constitutes a major pathway in the elimination of organic cations. In this report, the results of studies recently performed in this laboratory are presented. First, the molecular cloning of a novel splice variant of organic cation transporter from rat kidney (rOCTIA) is described. The functional characteristics of the transporter are discussed along with the implications of RNA splicing in enhancing transporter diversity. Second, the molecular cloning of the first human organic cation transporter (hOCTI) is described. Distinct interspecies differences in the tissue distribution and function of this transporter is presented. These studies have paved the way for elucidating molecular structure function relationships of organic cation transporters and for determining their physiologic role in drug absorption and elimination. The cloned transporters can be used in mammalian expression systems for screening candidate compounds identified during drug discovery and development and in the in vivo prediction of the pharmacokinetics of therapeutic agents. 相似文献
3.
Cathy Charles Jonathan Lomas Mita Giacomini Vandna Bhatia & Victoria A. Vincent 《The Milbank quarterly》1997,75(3):365-394
Four meanings of medical necessity have emerged, evolved, and dominated past and current health policy debates about the appropriate level of service coverage under Canada's health insurance program. To explore the shift in definition, provincial government and national health care association position papers responding to federal legislative and policy reviews of Canada's health insurance program from 1957 to 1984 were examined, as were more current reports on medical necessity. Four meanings of medical necessity predominated: "what doctors and hospitals do"; "the maximum we can afford"; "what is scientifically justified"; and "what is consistently funded across all provinces." These meanings changed with time as different stakeholder associations and governments redefined the concept of medical necessity to achieve different policy objectives for health service coverage under Canada's health insurance program. 相似文献
4.
The concentrative nucleoside transporter family,SLC28 总被引:13,自引:0,他引:13
The SLC28 family consists of three subtypes of sodium-dependent, concentrative nucleoside transporters, CNT1, CNT2, and CNT3 (SLC28A1, SLC28A2, and SLC28A3, respectively), that transport both naturally occurring nucleosides and synthetic nucleoside analogs used in the treatment of various diseases. These subtypes differ in their substrate specificities: CNT1 is pyrimidine-nucleoside preferring, CNT2 is purine-nucleoside preferring, and CNT3 transports both pyrimidine and purine nucleosides. Recent studies have identified key amino acid residues that are determinants of pyrimidine and purine specificity of CNT1 and CNT2. The tissue distributions of the CNTs vary: CNT1 is localized primarily in epithelia, whereas CNT2 and CNT3 have more generalized distributions. Nucleoside transporters in the SLC28 and SLC29 families play critical roles in nucleoside salvage pathways where they mediate the first step of nucleotide biosynthesis. In addition, these transporters work in concert to terminate adenosine signaling. SLC28 family members are crucial determinants of response to a variety of anticancer and antiviral nucleoside analogs, as they modulate the entry of these analogs into target tissues. Further, this family is involved in the absorption and disposition of many nucleoside analogs. Several CNT single nucleoside polymorphisms (SNPs) have been identified, but have yet to be characterized. 相似文献
5.
Giordani L Giacomini E Quaranta MG Viora M 《Clinical and experimental immunology》2000,122(3):358-363
We have previously demonstrated that exogenous Nef protein induced activation of normal human T cells up-regulating IL-15 production by monocytes. Since HIV-1 infection results in the early impairment of immune functions we decided to evaluate if Nef is able to modulate the induction of a specific antibody response. Human peripheral blood mononuclear cells from healthy donors were induced in vitro to mount a specific antibody response to the Candida albicans antigen. We show that Nef inhibited, in a dose-dependent manner, the induction of the anti-C. albicans antibody response. The ability of an anti-Nef antibody to prevent such inhibition indicates that the effect was indeed Nef-specific. In the Nef-treated cultures an early increase of IL-15 production was observed and the addition of anti-IL-15 antibody abrogated the Nef-induced inhibitory effect. Moreover the addition of IL-15 to the cultures inhibited, as well as Nef, the induction of the specific antibody response. Thus, our results suggest that Nef may inhibit the induction of a specific antibody response by an early up-regulation of IL-15 production. A better comprehension of this phenomenon may be important for unravelling some aspects of the B cell defects in HIV infection. 相似文献
6.
7.
8.
The effect of saturable binding to plasma proteins on the pharmacokinetic properties of disopyramide
Kathleen M. Giacomini Sarah E. Swezey Kathleen Turner-Tamiyasu Terrence F. Blaschke 《Journal of pharmacokinetics and pharmacodynamics》1982,10(1):1-14
Disopyramide exhibits saturable binding to plasma proteins in the therapeutic plasma concentration range. Because of this property, controversy exists in the literature regarding the pharmacokinetic properties of the drug. The purposes of this study were to reassess the pharmacokinetic properties of disopyramide in humans, taking into consideration both total and unbound concentrations and to use disopyramide as a model compound to study the effect of drug binding on the renal clearance of both total and unbound drug. A single intravenous dose of disopyramide (1.5 mg/kg) was administered to eight normal volunteers. Blood and urine samples were collected for 36h. Total concentrations of disopyramide in plasma and urine were determined by high pressure liquid chromatography. Binding of disopyramide to plasma proteins was determined by equilibrium dialysis. In all subjects, the binding of disopyramide to plasma proteins was saturable, but there were considerable differences in binding between subjects. The volume of distribution, total body clearance, and renal clearances of both total and unbound drug were calculated. Because only the total body clearance and renal clearance of unbound compound are not dependent upon unbound fraction (), these are the only parameters which can be reported without qualification as to the concentration. The mean ± SD total body clearance of unbound drug in the eight subjects was 5.40± 2.80 ml/min/kg. About 50% of this was due to renal elimination. A statistically significant negative correlation of the renal clearance of total disopyramide with time was observed in seven of eight subjects, whereas a significant correlation between the renal clearance of unbound disopyramide and time was observed in only one subject. This suggests that the renal clearance of unbound disopyramide is independent of , while the renal clearance of total disopyramide is dependent upon . 相似文献
9.
G Bacci A Briccoli M Rocca S Ferrari D Donati A Longhi F Bertoni P Bacchini S Giacomini C Forni M Manfrini S Galletti 《Annals of oncology》2003,14(7):1126-1134
BACKGROUND: Effective adjuvant or neoadjuvant regimens of chemotherapy have dramatically improved the prognosis of patients with high-grade osteosarcoma of the extremity, localized at diagnosis. Currently, little is known about patients with metastatic disease at presentation. PATIENTS AND METHODS: From May 1995 to May 2000, 57 patients with osteosarcoma of the extremity, metastatic at presentation, were treated according to the following scheme: primary chemotherapy, restaging, simultaneous resection of primary tumor and metastatic lesions, and maintenance chemotherapy. RESULTS: Thirty-five patients achieved remission. At a follow-up ranging from 2 to 7 years, seven remained continuously free of disease, one died of chemotherapy-related toxicity and 27 patients relapsed. Twenty-one of the 22 patients who never achieved remission died as a result of the tumor, as well as 20 of the 27 who achieved remission but then relapsed. Of the remaining seven relapsing patients, six are alive with uncontrolled disease, while one is alive and free of disease 24 months after the last post-relapse treatment. Two-year event-free survival (EFS) and overall survival (OS) were 21% and 55%, respectively. These results are significantly poorer than those achieved in 128 contemporary patients with non-metastatic disease at presentation, treated with the same chemotherapy protocol (2-year EFS and OS of 75% and 94%, respectively). CONCLUSIONS: The results of our study confirm that the prognosis of patients with osteosarcoma of the extremity, metastatic at presentation, remains poor, despite the use of aggressive treatments. 相似文献
10.
Impaired saccadic eye movement in diabetic patients: the relationship with visual pathways function 总被引:2,自引:0,他引:2
Alessandrini M Paris V Bruno E Giacomini PG 《Documenta ophthalmologica. Advances in ophthalmology》1999,99(1):11-20
The aim of this study was to evaluate whether a correlation existed between saccadic eye movements and visual pathways function
in diabetic patients. Saccadic or fast Eye Movement System (EMS) and Visual Evoked Potentials (VEPs) were assessed in 20 insulin-dependent
diabetic mellitus (IDDM) patients without long-term complications and in stable metabolic control and in 21 age-matched control
subjects. In IDDM patients we observed significantly (p<0.01) longer EMS latency, while EMS velocity and accuracy were similar to those of controls; VEPs showed a significant delay
in N75, P100, N145 latencies and significant reduction of N75-P100 and P100-N145 amplitudes. In IDDM patients no relationships
between EMS and VEP parameters were found. In conclusion, EMS latency delay suggests an impairment of the saccadic eye movement
system, while impaired VEPs may be ascribed to a dysfunction of the visual pathways. The lack of correlation between VEPs
impairment and EMS latency delay suggests that in our IDDM patients the delay of saccadic latency cannot be exclusively related
to a visual pathways dysfuction and could be ascribed to a diffuse neuronal involvement.
This revised version was published online in July 2006 with corrections to the Cover Date. 相似文献